Risk of bacteremia in patients with hematological and other malignancies after initial placement of a central venous catheter

Journal of Long-Term Effects of Medical Implants

Volumn 17, Issue 4, 2007, Pages 303-311

  Pedersen, Gitte ^a   Nørgaard, Mette ^a   Kiiveri, Mathilda ^a   Schønheyder, Henrik Carl ^a   Larsson, Heidi ^a   Stolberg, Erik ^a   Andersen, Petra Witt ^a   Sørensen, Henrik Toft ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Bacteremia; Central venous device; Malignancy

Indexed keywords

BLOOD; CATHETERS; HOSPITALS; TUMORS;

BACTEREMIA; CANCER PATIENTS; CATHETER PLACEMENT; CENTRAL VENOUS DEVICE; FOLLOW-UP STUDIES; HEMATOLOGICAL MALIGNANCIES; MALIGNANCY; RELATIVE RISKS;

BACTERIOLOGY;

EID: 62449215062     PISSN: 10506934     EISSN: None     Source Type: Journal    
DOI: 10.1615/JLongTermEffMedImplants.v17.i4.40     Document Type: Article

References (30)

1. Rintala E. Incidence and clinical significance of positive blood cultures in febrile episodes of patients with hematological malignancies. Scand J Infect Dis. 1994;26:77-84.
2. Pagano L, Tacconelli E, Tumbarello M et al. Bacteremia in patients with hematological malignancies. analysis of risk factors, etiological agents and prognostic indicators. Hematologica. 1997;82:415-9.
3. Escande MC, Herbrecht R. Prospective study of bacteremia in cancer patients. Results of a French multicentre study. Support Care Cancer. 1998;6:273-80.
4. Lane RK, Matthay MA. Central line infections. Curr Opin Crit Care. 2002;8:441-8.
5. Cortelezzi A, Fracchiolla NS, Maisonneuve P, Moia M, Luchesini C, Ranzi ML, Monni P, Pasquini MC, Lambertenghi-Deliliers G. Central venous catheter-related complications in patients with hematological malignancies: a retrospective analysis of risk factors and prophylactic measures. Leuk Lymphoma. 2003:44:1495-501.
6. Fatkenheuer G, Cornely O, Seifert H. Clinical management of catheter-related infections. Clin Microbiol Infect. 2002;8:545-50.
7. Andersen TF, Madsen M, Jorgensen J et al. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999;46:263-8.
8. Schonheyder HC, Hojbjerg T. The impact of the first notification of positive blood cultures on antibiotic therapy. a one-year survey. APMIS. 1995;103:37-44.
9. Maki DG, Weise CE, Sarafin HW. A semi-quantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med. 1977;296:1305-9.
10. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-83.
11. Pracchia LF, Dias LC, Dorlhiac-Llacer PE, Chamone DD. Comparison of catheter-related infection risk in two different long-term venous devices in adult hematology-oncology patients. Rev Hosp Clin Fac Med Sao Paulo. 2004;59:291-5.
12. Groeger JS, Lucas AB, Th aler HT, Friedlander-Klar H, Brown AE, Kiehn TE, Armstrong D. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med. 1993;119:1168-74.
13. Johansson E, Bjorkholm M, Bjorvell H, et al. Totally implantable subcutaneous port system versus central venous catheter placed before induction chemotherapy in patients with acute leukemia-a randomized study. Support Care Cancer. 2004;12:99-105.
14. Fatkenheuer G, Buchheidt D, Cornely OA et al. Central venous catheter (CVC)-related infections in neutropenic patients. guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol. 2003;82(Suppl 2):S149-57.
15. Biffi R, Pozzi S, Agazzi A, Pace U, Floridi A, Cenciarelli S, Peveri V, Cocquio A, Andreoni B, Martinelli G. Use of totally implantable central venous access ports for high-dose chemotherapy and peripheral blood stem cell transplantation: results of a monocentre series of 376 patients. Ann Oncol. 2004;15:296-300.
16. Biffi R, de Braud F, Orsi F, Pozzi S, Mauri S, Goldhirsch A, Nolè F, Andreoni B. Totally implantable central venous access ports for long-term chemotherapy. Ann Oncol. 1998;9:767-73.
17. Blot F, Nitenberg G, Brun-Buisson C. New tools in diagnosing catheter-related infections. Support Care Cancer. 2000;8:287-92.
18. Raad II, Hanna HA. Intravascular catheter-related infections: new horizons and recent advances. Arch Intern Med. 2002;162:871-8.
19. Raad I, Hanna HA, Alakech B, Chatzinikolaou I, Johnson MM, Tarrand J. Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections. Ann Intern Med. 2004;140:18-25.
20. Blot F, Schmidt E, Nitenberg G, Tancrède C, Leclercq B, Laplanche A, Andremont A. Earlier positivity of central-venous- versus peripheral-blood cultures is highly predictive of catheter-related sepsis. J Clin Microbiol. 1998;36:105-9.
21. Seifert H, Cornely O, Seggewiss K, Decker M, Stefanik D, Wisplinghoff H, Fätkenheuer G. Bloodstream infection in neutropenic cancer patients related to short-term nontunnelled catheters determined by quantitative blood cultures, differential time to positivity, and molecular epidemiological typing with pulsed-field gel electrophoresis. J Clin Microbiol. 2003;41:118-23.
22. Rotstein C, Brock L, Roberts RS. The incidence of first Hickman catheter-related infection and predictors of catheter removal in cancer patients. Infect Control Hosp Epidemiol. 1995;16:451-8.
23. Soo RA, Gosbell IB, Gallo JH, Harvey MP, Dunlop L, Motum P, Rosenfeld D. Hickman catheter complications in a hematology unit, 1996-98. Intern Med J. 2002;32:100-3.
24. Coyle VM, McMullan R, Morris TCM, Rooney PJ, Hedderwick S. Catheter-related bloodstream infection in adult hematology patients: catheter removal practice and outcome. J Hosp Infect. 2004;57:325-31.
25. Favre B, Hugonnet S, Correa L, Sax H, Rohner P, Pittet D. Nosocomial bacteremia: clinical significance of a single blood culture positive for coagulase-negative staphylococci. Infect Control Hosp Epidemiol. 2005;26:697-702.
26. Rijnders BJA, Wijngaerden E, Vandecasteele SJ and Peetermans WE. Uncertainties and future research topics in the management of suspected catheter-related infection. Clin Inf Dis 2001;33:1946.
27. Wright SB, Huskins WC, Dokholyan RS, Goldmann DA, Platt R. Administrative databases provide inaccurate data for surveillance of long-term central venous catheter-associated infections. Infect Control Hosp Epidemiol. 2003;24:946-9.
28. Nørgaard M, Skriver MV, Gregersen H, Pedersen G, Schønheyder HC, Sørensen HT. The data quality of haematological malignancy ICD-10 diagnoses in a population-based Hospital Discharge Registry. Eur J Canc Prev. 2005;14:201-6.
29. Velasco E, Soares M, Byington R, Martins CA, Schirmer M, Dias LM, Goncalves VM. Prospective evaluation of the epidemiology, microbiology, and outcome of bloodstream infections in adult surgical cancer patients. Eur J Clin Microbiol Infect Dis. 2004;23:596-602.
30. Wilchesky M, Tamblyn RM, Huang A. Validation of diagnostic codes within medical services claims. J Clin Epidemiol. 2004;57:131-41.